PI Industries to acquire TRM India, Solis Pharma and Archimica

28 Apr 2023 , 11:52 AM

On Thursday in an exchange filing, PI industries has said that its wholly-owned subsidiary PI Health Sciences Ltd has entered into the share purchase agreements with Therachem Research Medilab LLC (TRM) to purchase its arms in India i.e. TRM India and Solis Pharma Chem.

It has also signed a definitive agreement with Plahoma Twelve GmbH to purchase a 100% share in Archimica S.p.A. (Archimica). The same is being purchased for €34.2 million. Archimica serves over 60 clients in more than 30 nations. It is a CDMO and manufacturer of small molecule APIs with headquarters in Italy.

TRM US, along with its subsidiaries TRM India and Solis Pharmachem, is involved in the research, development, and production of chemical compounds and key starting materials. These materials are crucial for the manufacturing of active pharmaceutical ingredients (APIs) as well as other pharmaceutical products.

On the other hand, Archimica is an Italy-based small molecule API manufacturer and a CDMO servicing over 60 marquee customers in more than 30 countries. Archimica owns 24 US DMFs, GMP manufacturing facility for APIs and Intermediates across wide therapeutic and substance classes such as Oncology, Anti Ulcer, and Anti Arthritis.